Early clearance of a thymidine kinase-deficient strain of herpes simplex virus type 2 from the female genital tract required T-cell-produced gamma interferon (IFN-␥). Transfer of activated CD8
Resolution of herpes simplex virus (HSV) lesions from epithelial sites of infection is achieved in healthy individuals by cellular immune mechanisms, but this process may be impaired in immunocompromised individuals. Understanding the cellular and molecular events involved in lesion resolution may be important for the development of therapies to decrease the severity of HSV lesions in these individuals. However, the exact mechanisms involved in clearance of HSV-2 from the genital epithelium are not fully understood. CD8 ϩ T cells have been identified as important for clearance of genital herpetic lesions, a process that involves both gamma interferon (IFN-␥) secretion and cytolytic mechanisms (6, 7, 12, 13) . IFN-␥ is a major mediator of HSV-2 clearance (5, 17, 18, 20, 22, 24) , presumably due to the activation of multiple immune cell types and/or initiation of numerous antiviral pathways in somatic cells. However, the cell types responding to IFN-␥ in the female genital tract and the antiviral mechanisms relevant to the resolution of HSV-2 lesions are not understood.
IFN-␥ in the genital secretions of fully immunocompetent mice is derived primarily from NK cells and antigen-specific T lymphocytes, with NK-cell-produced IFN-␥ peaking at day 2 after intravaginal (ivag) inoculation and T-cell-produced IFN-␥ present after day 3 (2, 17) . To test if non-T-cell sources of IFN-␥ were sufficient for HSV-2 clearance, Rag1-deficient mice (Rag1 Ϫ/Ϫ ) genetically deficient in adaptive immune cells but possessing an intact innate immune system, including macrophages, dendritic cells, and NK cells (19) , were utilized as recipients of activated wild-type OT-I or IFN-␥-deficient OT-I (OT-I IFN Ϫ/Ϫ ) T cells. Mice were treated with medroxyprogesterone in all experiments to induce susceptibility to genital HSV-2 inoculation (15), most likely reflecting hormonal induction of the HSV entry receptor, nectin-1, on vaginal epithelial cells (14) . Rag1 Ϫ/Ϫ mice were injected intravenously (i.v.) with 3 ϫ 10 6 activated OT-I or OT-I IFN Ϫ/Ϫ T cells and then challenged ivag with 5 ϫ 10 3 PFU of an ovalbumin-expressing virus, HSV-2 tk Ϫ OVA (7). HSV-2 tk Ϫ strains replicate similarly to wild-type HSV-2 in genital epithelial cells but do not replicate well in neurons (15) , therefore development of encephalitis and mortality does not occur following ivag inoculation, as is common following inoculation with wild-type HSV-2 (15, 18) . The use of a tk Ϫ HSV-2 strain in the present study therefore allowed a focused examination of the T-cell-mediated mechanisms of virus clearance from the genital tract. To confirm the presence of NK cells in the genital epithelia of recipient mice, the vaginae and cervices were dissected from groups of uninfected or HSV-2 tk Ϫ OVA-infected Rag1 Ϫ/Ϫ mice three days after virus inoculation and mechanically dissociated. The leukocyte fraction was isolated over Histopaque and stained with fluorescein isothiocyanate-anti NK1.1 or isotype control antibodies. A small population of NK1.1 ϩ cells was detected in the genital tracts of uninfected Rag1 Ϫ/Ϫ mice (Fig. 1A) ; however, this population increased following ivag HSV-2 tk Ϫ OVA inoculation (Fig. 1B) .
Rag1
Ϫ/Ϫ mice receiving activated wild-type OT-I cells cleared virus by day 6 postchallenge (Fig. 2A) . However, activated OT-I IFN-␥ Ϫ/Ϫ T-cell recipients were unable to clear HSV-2 tk Ϫ OVA from the genital tract, and 75% (n ϭ 8) of these mice continued to shed virus through day 21 postinoculation (Fig. 2B ). These data, together with previous results demonstrating that less IFN-␥ is produced by NK cells than with antigen-specific T cells (17) , suggest that insufficient NKcell-produced IFN-␥ was available to achieve virus clearance and that T-cell-produced IFN-␥ was required for resolution of the genital infection. These results do not preclude the possibility that other proinflammatory cytokines were also involved in HSV-2 clearance such as tumor necrosis factor alpha or interluekin-15 (8, 11, 21).
Cantin et al. showed that mice genetically deficient in the IFN-␥ receptor (IFN-␥R
Ϫ/Ϫ ) were significantly more susceptible to ocular challenge with virulent HSV-1 than were wildtype controls (5) . Therefore, as a further test for the importance of IFN-␥ in virus clearance, IFN-␥R Ϫ/Ϫ mice (10) and C57BL/6 (B6) mice were sublethally irradiated (650 rads), repopulated with activated OT-I T cells, and inoculated ivag with HSV-2 tk Ϫ OVA. The majority of B6 mice receiving activated OT-I T cells cleared virus by day 8, and all these recipients cleared by day 10 (Fig. 3A) . Virus titers in IFN-␥R Ϫ/Ϫ recipient mice were significantly greater than in B6 OT-I recipients through day 21, although virus titers began dropping by day 18. Eighty-eight percent (n ϭ 8) of the IFN-␥R Ϫ/Ϫ mice were still shedding high titers of virus on day 16, but only 38% were on day 21 (Fig. 3B) . Together these results demonstrate a requirement for recipient expression of IFN-␥R to achieve rapid virus clearance but suggest an IFN-␥R-independent antiviral mechanism may have been acting much later in infection.
We previously showed that activated OT-I T cells infiltrated the vaginal tracts of HSV-2 tk Ϫ OVA-infected, but not uninfected, mice (7) . In agreement with our previous results, CD8 ϩ T cells were detected in the vaginae of OT-I recipient mice on day 7 after ivag inoculation with HSV-2 tk Ϫ OVA (Fig. 4A) . Further, T cells obtained from the vaginae of identically treated mice produced IFN-␥ upon culture with mitomycin C-treated syngeneic spleen cells pulsed with the immunogenic OVA peptide, SIINFEKL (Fig. 4B) . Thus, IFN-␥-producing OT-I T cells were present at the site of genital infection at a time concurrent with virus clearance.
The IFN-␥R is expressed on nearly all nucleated cells (1, 3) , and studies have shown that vaginal epithelial cells expressed class II major histocompatibility complex proteins upon expo- These data suggest rapid clearance of HSV-2 is correlated with IFN-␥R expression on genital parenchymal cells. These results are consistent with a recent report that clearance of lymphocytic choriomeningitis virus was dependent on parenchymal cell expression of the IFN-␥R (9). The delayed clearance in R Ϫ/Ϫ R Ϫ/Ϫ chimeras (Fig. 4C ) and IFN-␥R Ϫ/Ϫ recipients (Fig. 3A) suggests the presence of a less-efficient, IFN-␥R-independent antiviral mechanism, distinct from the IFN-␥R-dependent mechanism responsible for early resolution of infection. This late-acting mechanism apparently did not require IFN-␥R expression on either transferred hematopoietic cells or on the genital parenchymal cells and may have involved enhanced production of cytokines such as IFN-␣/␤, tumor necrosis factor alpha, or interleukin-15 which are thought to be involved in controlling HSV infections (4, 8, 11, 21) . Because the transfer of accessory cells alone did not mediate clearance (Fig. 4) , the process also involved the activity of T lymphocytes. The difference in clearance kinetics between IFN-␥R Ϫ/Ϫ recipient mice (Fig. 3) and IFN-␥R (Fig. 4C ) most likely reflects differences in experimental design. The IFN-␥R Ϫ/Ϫ recipients (Fig. 3) were irradiated and reconstituted only with activated OT-I T cells immediately before virus inoculation, whereas radiation chimeras received T-cell-depleted accessory cells from bone marrow and spleen one week before T-cell reconstitution and virus The authors have no conflicting financial interests.
